Literature DB >> 19197341

Short synthesis of a novel class of salvinorin A analogs with hemiacetalic structure.

Ruslan V Bikbulatov1, Jeremy Stewart, Wentao Jin, Feng Yan, Bryan L Roth, Daneel Ferreira, Jordan K Zjawiony.   

Abstract

Novel semisynthetic analogs of salvinorin A, a full agonist having extraordinary affinity as well as selectivity for the κ-opioid receptor (KOR), were obtained in good yields. The derivatives are remarkable for their unusual and unique hemiacetal structure in the salvinorin series of compounds. The formation of the hemiacetal occurs with epimerization at C-12, thus preserving the original configuration of salvinorin A. The dimethyl ester derivative of the hemiacetal was found to have an affinity for both KOR and MOR (μ-opioid receptor).

Entities:  

Year:  2008        PMID: 19197341      PMCID: PMC2344139          DOI: 10.1016/j.tetlet.2007.12.041

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

Authors:  David Y W Lee; Minsheng He; Lee-Yuan Liu-Chen; Yulin Wang; Jian-Guo Li; Wei Xu; Zhongze Ma; William A Carlezon; Bruce Cohen
Journal:  Bioorg Med Chem Lett       Date:  2006-08-30       Impact factor: 2.823

2.  Synthesis of salvinorin A analogues as opioid receptor probes.

Authors:  Kevin Tidgewell; Wayne W Harding; Anthony Lozama; Howard Cobb; Kushal Shah; Pavitra Kannan; Christina M Dersch; Damon Parrish; Jeffrey R Deschamps; Richard B Rothman; Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2006-06       Impact factor: 4.050

3.  Salvinorin A: allosteric interactions at the mu-opioid receptor.

Authors:  Richard B Rothman; Daniel L Murphy; Heng Xu; Jonathan A Godin; Christina M Dersch; John S Partilla; Kevin Tidgewell; Matthew Schmidt; Thomas E Prisinzano
Journal:  J Pharmacol Exp Ther       Date:  2006-10-23       Impact factor: 4.030

4.  Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum.

Authors:  L J Valdés; H M Chang; D C Visger; M Koreeda
Journal:  Org Lett       Date:  2001-11-29       Impact factor: 6.005

5.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.

Authors:  Wayne W Harding; Matthew Schmidt; Kevin Tidgewell; Pavitra Kannan; Kenneth G Holden; Brian Gilmour; Hernan Navarro; Richard B Rothman; Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2006-01       Impact factor: 4.050

6.  Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.

Authors:  Wayne W Harding; Kevin Tidgewell; Matthew Schmidt; Kushal Shah; Christina M Dersch; John Snyder; Damon Parrish; Jeffrey R Deschamps; Richard B Rothman; Thomas E Prisinzano
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

7.  An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.

Authors:  C E Groer; K Tidgewell; R A Moyer; W W Harding; R B Rothman; T E Prisinzano; L M Bohn
Journal:  Mol Pharmacol       Date:  2006-11-07       Impact factor: 4.436

Review 8.  Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

Authors:  L J Valdés
Journal:  J Psychoactive Drugs       Date:  1994 Jul-Sep

9.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.

Authors:  Kenneth G Holden; Kevin Tidgewell; Alfred Marquam; Richard B Rothman; Hernán Navarro; Thomas E Prisinzano
Journal:  Bioorg Med Chem Lett       Date:  2007-09-15       Impact factor: 2.823

10.  Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.

Authors:  Denise S Simpson; Peter L Katavic; Anthony Lozama; Wayne W Harding; Damon Parrish; Jeffrey R Deschamps; Christina M Dersch; John S Partilla; Richard B Rothman; Hernan Navarro; Thomas E Prisinzano
Journal:  J Med Chem       Date:  2007-06-20       Impact factor: 7.446

View more
  4 in total

Review 1.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

2.  Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.

Authors:  David Y W Lee; Lu Yang; Wei Xu; Gang Deng; Lin Guo; Lee-Yuan Liu-Chen
Journal:  Bioorg Med Chem Lett       Date:  2010-08-05       Impact factor: 2.823

3.  Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.

Authors:  Cécile Béguin; Katharine K Duncan; Thomas A Munro; Douglas M Ho; Wei Xu; Lee-Yuan Liu-Chen; William A Carlezon; Bruce M Cohen
Journal:  Bioorg Med Chem       Date:  2008-12-14       Impact factor: 3.641

4.  Synthesis of deacetyl-1,10-didehydrosalvinorin G.

Authors:  Zhongze Ma; David Y W Lee
Journal:  Tetrahedron Lett       Date:  2008-03-10       Impact factor: 2.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.